Nasdaq biotech index hits over 2-1/2 yr high
** Shares of the Nasdaq biotech index up 1.3% at 4.885.99
points in afternoon trading
** Index hits over 2-1/2 yr high
** Early stage biotechs rely heavily on venture capital and
public listings as their financing options; IPO investment in
biotechs is showing signs of further recovery this year
** Top movers include Pacific Biosciences PACB.O , Caribou
Biosciences CRBU.O and Grail GRAL.O
** The index has risen 6.8% in the week ended July 12
** YTD, the index is up 11.8%
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com;))
Recent news on Pacific Biosciences of California
See all newsBrief: Pacbio And Verily Health Announce Multi-Year Strategic Collaboration
Pacific Biosciences of California, Inc. reports results for the quarter ended June 30 - Earnings Summary
Pacific Biosciences Q2 adj. loss bigger than estimates on margin pressure
Brief: Pacific Biosciences of California Q2 EPS USD -0.14
Pacific Biosciences of California Inc expected to post a loss of 13 cents a share - Earnings Preview